Essais liés4clinical trials
VilleNew Orleanslocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT03235479

Ouvrir le site du centre

Essais cliniques associés

4
MoléculeIndication / populationPhaseNCTTitreStatut
Atogepant Migraine Phase 3 NCT03777059 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine COMPLETED
Rimegepant Migraine Phase 3 NCT03235479 Safety and Efficacy Study in Adult Subjects With Acute Migraines COMPLETED
Rimegepant Migraine Phase 3 NCT03461757 Trial in Adult Subjects With Acute Migraines COMPLETED
Rimegepant Migraine Phase 2/3 NCT03266588 Open Label Safety Study in Acute Treatment of Migraine COMPLETED